Karuna Jayathilake

1.0k total citations
24 papers, 812 citations indexed

About

Karuna Jayathilake is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Karuna Jayathilake has authored 24 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Karuna Jayathilake's work include Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (11 papers) and Tryptophan and brain disorders (4 papers). Karuna Jayathilake is often cited by papers focused on Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (11 papers) and Tryptophan and brain disorders (4 papers). Karuna Jayathilake collaborates with scholars based in United States, United Kingdom and South Korea. Karuna Jayathilake's co-authors include Herbert Y. Meltzer, Neil D. Woodward, Edward Perry, William V. Bobo, Benoît M. Dawant, Rui Li, M. Sib Ansari, Patrizia Riccardi, Robert Kessler and Stefania Bonaccorso and has published in prestigious journals such as Biological Psychiatry, Psychological Medicine and Frontiers in Microbiology.

In The Last Decade

Karuna Jayathilake

24 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karuna Jayathilake United States	17	537	218	126	108	103	24	812
Claudia Mehler‐Wex Germany	21	609 1.1×	111 0.5×	150 1.2×	93 0.9×	143 1.4×	50	1.1k
Christopher M. Marano United States	12	264 0.5×	129 0.6×	126 1.0×	127 1.2×	131 1.3×	12	687
Timothy L. Holman United States	15	496 0.9×	147 0.7×	152 1.2×	136 1.3×	78 0.8×	22	896
G. Remington Canada	8	468 0.9×	184 0.8×	96 0.8×	80 0.7×	91 0.9×	8	712
Atheeshaan Arumuham United Kingdom	8	517 1.0×	88 0.4×	117 0.9×	177 1.6×	104 1.0×	19	907
Tomoyuki Nagata Japan	18	319 0.6×	113 0.5×	176 1.4×	243 2.3×	144 1.4×	56	789
Fernando Sarramea Spain	21	482 0.9×	139 0.6×	110 0.9×	109 1.0×	382 3.7×	48	968
Sean W. Flynn Canada	11	219 0.4×	245 1.1×	165 1.3×	52 0.5×	188 1.8×	17	907
Belmaker Rh Israel	13	354 0.7×	113 0.5×	87 0.7×	73 0.7×	42 0.4×	40	712
Koichi Ohara Japan	17	315 0.6×	322 1.5×	230 1.8×	57 0.5×	145 1.4×	36	888

Countries citing papers authored by Karuna Jayathilake

Since Specialization

Citations

This map shows the geographic impact of Karuna Jayathilake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karuna Jayathilake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karuna Jayathilake more than expected).

Fields of papers citing papers by Karuna Jayathilake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karuna Jayathilake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karuna Jayathilake. The network helps show where Karuna Jayathilake may publish in the future.

Co-authorship network of co-authors of Karuna Jayathilake

This figure shows the co-authorship network connecting the top 25 collaborators of Karuna Jayathilake. A scholar is included among the top collaborators of Karuna Jayathilake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karuna Jayathilake. Karuna Jayathilake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Massey, Bill W., Karuna Jayathilake, & Herbert Y. Meltzer. (2020). Respiratory Microbial Co-infection With SARS-CoV-2. Frontiers in Microbiology. 11. 2079–2079. 40 indexed citations

Jayathilake, Karuna, et al.. (2015). Decreased serotonin2C receptor responses in male patients with schizophrenia. Psychiatry Research. 226(1). 308–315. 5 indexed citations

Meltzer, Herbert Y., et al.. (2014). A six month randomized controlled trial of long acting injectable risperidone 50 and 100 mg in treatment resistant schizophrenia. Schizophrenia Research. 154(1-3). 14–22. 26 indexed citations

Meltzer, Herbert Y., et al.. (2011). A 12-Month Randomized, Open-Label Study of the Metabolic Effects of Olanzapine and Risperidone in Psychotic Patients. The Journal of Clinical Psychiatry. 72(12). 1602–1610. 34 indexed citations

Bobo, William V., et al.. (2011). The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial. Schizophrenia Research. 130(1-3). 106–113. 34 indexed citations

Bobo, William V., Stefania Bonaccorso, Karuna Jayathilake, & Herbert Y. Meltzer. (2011). Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder. Psychiatry Research. 189(2). 200–207. 10 indexed citations

Bobo, William V., Karuna Jayathilake, Myung A. Lee, & Herbert Y. Meltzer. (2010). Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics. Psychiatry Research. 176(2-3). 114–119. 5 indexed citations

Meltzer, Herbert Y., William V. Bobo, Myung A. Lee, Philip A. Cola, & Karuna Jayathilake. (2010). A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry Research. 177(3). 286–293. 27 indexed citations

Bobo, William V., Karuna Jayathilake, Myung A. Lee, & Herbert Y. Meltzer. (2009). Melperone, an aytpical antipsychotic drug with clozapine‐like effect on plasma prolactin: contrast with typical neuroleptics. Human Psychopharmacology Clinical and Experimental. 24(5). 415–422. 3 indexed citations

10.

Meltzer, Herbert Y., Meagan Brennan, Neil D. Woodward, & Karuna Jayathilake. (2008). Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder. Schizophrenia Research. 106(2-3). 258–264. 25 indexed citations

11.

Kessler, Robert, M. Sib Ansari, Patrizia Riccardi, et al.. (2006). Occupancy of Striatal and Extrastriatal Dopamine D2 Receptors by Clozapine and Quetiapine. Neuropsychopharmacology. 31(9). 1991–2001. 101 indexed citations

12.

Kessler, Robert, M. Sib Ansari, Patrizia Riccardi, et al.. (2005). Occupancy of Striatal and Extrastriatal Dopamine D2/D3 Receptors by Olanzapine and Haloperidol. Neuropsychopharmacology. 30(12). 2283–2289. 65 indexed citations

13.

Sumiyoshi, Tomiki, et al.. (2004). Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia. Psychopharmacology. 177(1-2). 79–83. 12 indexed citations

14.

Ertuğrul, Aygün, James L. Kennedy, Mario Masellis, et al.. (2003). No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia. Schizophrenia Research. 69(2-3). 301–305. 25 indexed citations

15.

Meltzer, Herbert Y., Edward Perry, & Karuna Jayathilake. (2002). Clozapine-induced weight gain predicts improvement in psychopathology. Schizophrenia Research. 59(1). 19–27. 108 indexed citations

16.

Meltzer, Herbert Y. & Karuna Jayathilake. (1999). Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine?. PubMed. 60 Suppl 10. 47–51. 47 indexed citations

17.

Sumiyoshi, Tomiki, et al.. (1997). Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine. Psychiatry Research. 69(2-3). 113–121. 23 indexed citations

18.

Sumiyoshi, Tomiki, et al.. (1997). Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: Relation to neuroleptic resistance. Biological Psychiatry. 41(5). 560–566. 25 indexed citations

19.

Maes, Michaël, Joseph R. Calabrese, Karuna Jayathilake, & Herbert Y. Meltzer. (1997). Effects of subchronic treatment with valproate on l-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission. Psychiatry Research. 71(2). 67–76. 32 indexed citations

20.

Findling, Robert L., Karuna Jayathilake, & Herbert Y. Meltzer. (1996). Pre-morbid asociality in neuroleptic-resistant and neuroleptic-responsive schizophrenia. Psychological Medicine. 26(5). 1033–1041. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact